A panelist discusses how the historical standard of care for metastatic squamous cell anal carcinoma evolved from ...

A panelist discusses how squamous cell cancer of the anal canal has nearly doubled in incidence over 30 years, with human ...

Investigators examined the effect of immunosuppression on poor outcomes among patients with cutaneous squamous cell carcinoma.

Aprea Therapeutics Inc. has announced new preclinical data on APR-1051, the company’s next-generation oral WEE1 inhibitor, in ...

Jessie J shared insight into her recovery from breast cancer surgery, including how her family has been supporting her and ...

The company said the therapy is the first allogenic therapy developed with its Tmod technology to be tested in humans.

Panelists discuss how anal cancer epidemiology shows increasing incidence in both sexes with HPV infection as the primary risk factor, affecting predominantly women with a median age of 60, while ...

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has revealed new preclinical findings and a clinical update on ...

Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are ...

A new study explores a one-and-done radiotherapy for non-melanoma skin cancer – no scalpels, no stitches, just science.